12:00 AM
 | 
Apr 12, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Asimadoline: SPA received

Tioga received an SPA from FDA for a pair of planned Phase III trials of asimadoline, the first of which is slated to begin this month. The...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >